参考文献/References:
［1］ Akiyama M, Miyaaki H, Miuma S, et al. Significance of trans- hepatic arterial chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus［J］. Oncol Rep, 2008, 20: 353- 357.
［2］ Ando E, Yamashita F, Tanaka M, et al. A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein［J］. Cancer, 1997, 79: 1890- 1896.
［3］ Okazaki M, Yamasaki S, Ono H, et al. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy［J］. Hepatogastroenterology, 1993, 40: 320- 323.
［4］ Izaki K, Sugimoto K, Sugimura K, et al. Transcatheter arterial embolization for advanced tumor thrombus with marked arterioportal or arteriovenous shunt complicating hepatocellular carcinoma［J］. Radiat Med, 2004, 22: 155- 162.
［5］ Yamakado K, Tanaka N, Nakatsuka A, et al. Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein［J］. J Hepatol, 1999, 30:660- 668.
［6］ 龚高全， 王小林， 周康荣， 等． 肝癌伴门静脉癌栓的金属内支架治疗的初步研究［J］． 临床放射学杂志， 2003， 22: 498- 500．
［7］ 张 磊， 陆骊工， 李 勇， 等． 门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究［J］． 介入放射学杂志， 2011， 20： 968- 973．
［8］ Yamada K, Izaki K, Sugimoto K, et al. Prospective trial of combined transcatheter arterial chemoembolization and three- dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma［J］. Int J Radiat Oncol Biol Phys, 2003, 57: 113- 119.
［9］ Kim DY, Park W, Lim DH, et al. Three- dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma［J］. Cancer, 2005, 103: 2419- 2426.
［10］ 曾昭冲， 汤钊猷， 樊 嘉， 等． 肝细胞肝癌伴门静脉/下腔静脉癌栓接受与不接受放射治疗的比较［J］． 癌症进展， 2006， 4: 284- 295， 307．
［11］ 徐爱兵， 苏小琴， 彭春雷， 等． 肝动脉化疗栓塞联合三维适形放疗治疗肝癌合并门脉癌栓的临床对照研究［J］． 胃肠病学和肝病学杂志， 2007， 16: 323- 325．
［12］ 吴志军， 蔡 晶， 徐爱兵， 等． 三维适形放疗联合肝动脉化疗栓塞治疗肝癌伴门脉癌栓的临床观察［J］． 中华医学杂志， 2011， 91: 2841- 2844．
［13］ 王向前， 蔡 晶， 张一心， 等． 三维适形放疗联合肝动脉化疗栓塞治疗肝癌伴门脉癌栓的疗效及预后分析［J］． 南通大学学报:医学版， 2013， 33： 372- 375．
［14］ Zhang XB, Wang JH, Yan ZP, et al. Hepatocellular carcinoma with main portal vein tumor thrombus: treatment with 3- dimensional conformal radiotherapy after portal vein stenting and transarterial chemoembolization［J］. Cancer, 2009, 115: 1245- 1252.
［15］ Nakagawa K, Yamashita H, Shiraishi K, et al. Radiation therapy for portal venous invasion by hepatocellular carcinoma［J］. World J Gastroenterol, 2005, 11: 7237- 7241.
［16］ Ishikura S, Ogino T, Furuse J, et al. Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus［J］. Am J Clin Oncol, 2002, 25: 189- 193.
［17］ 刘 岩， 刘瑞宝， 王 平， 等． 经导管植入125I放射性粒子治疗肝癌伴门静脉癌栓19例［J］． 介入放射学杂志， 2014， 23： 35- 37．
［18］ 翁志成， 杨维竹， 江 娜， 等． CT引导下125I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价［J］． 介入放射学杂志， 2010， 19: 535- 539．
［19］ 李 说， 颜志平， 张 雯， 等． 兔门静脉主干内植入连续排列125I粒子条的实验研究［J］． 介入放射学杂志， 2009， 18： 607- 611．
［20］ 刘清欣， 颜志平， 李 说， 等． 125I粒子条联合门静脉支架及化疗栓塞治疗原发性肝癌合并门静脉癌栓［J］． 介入放射学杂志， 2009， 18： 593- 595．
［21］ 方主亭， 颜志平， 罗剑钧， 等. 腔内植入125I粒子条联合经肝动脉化疗栓塞术治疗肝癌合并广泛性门静脉癌栓的疗效观察［J］. 中华肝脏病杂志， 2013， 21： 146- 149.
［22］ Luo J, Yan Z, Liu Q, et al. Endovascular placement of iodine- 125 seed Strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein［J］. J Vasc Interv Radiol, 2011, 22: 479- 489.
［23］ 吴林霖， 罗剑钧， 颜志平， 等． 门脉支架及TACE联合或未联合血管内植入碘-125（125I）粒子条治疗肝癌合并门脉主干癌栓（MPVTT）的随机对照研究［J］． 复旦学报:医学版， 2013， 40: 354- 359．
相似文献/References:
[1]申淑群,杨业发,葛乃建,等.肝癌破裂出血的介入与外科手术疗效评价[J].介入放射学杂志,2010,(07):544.
SHEN Shuqun,YANG Yefa,GE Naijian,et al.Evaluation of interventional and surgical treatments for the hemorrhage of ruptured hepatocellular carcinoma[J].journal interventional radiology,2010,(12):544.
[2]郑加生,崔雄伟,禹纪红.自发性肝癌破裂出血的急诊动脉栓塞治疗[J].介入放射学杂志,2006,(04):228.
ZHANG Jia-sheng,CUI Xiong-wei,YU Ji-hong,et al.Emergency transcatheter arterial embolization for beeding of hepatocellular carcinoma spontaneous rupture[J].journal interventional radiology,2006,(12):228.
[3]李强,曾从俊,王莺.化疗栓塞联合质子放射治疗肝癌合并门脉主干癌栓的临床应用[J].介入放射学杂志,2009,(04):278.
LI Qiang,ZENG Congjun,WANG Ying.Interventional chemoembolization combined with proton radiotherapy for the treatment of hepatocellular carcinoma accompanied with portal cancerous thrombus[J].journal interventional radiology,2009,(12):278.
[4]张长青,吴伟岗,曾志雄,等.肝动脉化疗栓塞及注射~(32)P-胶体、无水乙醇综合序贯介入治疗原发性肝癌疗效分析[J].介入放射学杂志,2000,(01):22.
[5]经 翔,丁建民,王彦冬,等. 射频消融和微波消融治疗肝癌的比较[J].介入放射学杂志,2014,(04):306.
JING Xiang,DING Jian? min,WANG Yan? dong,et al. Ultrasound-guided percutaneous radiofrequency ablation and microwave ablation for the treatment of hepatocellular carcinoma： a comparison study[J].journal interventional radiology,2014,(12):306.
[6]钱 晟,刘 嵘,王建华,等.栓塞肝动脉-门静脉瘘在TACE联合门静脉支架治疗肝癌伴门静脉癌栓中的临床意义[J].介入放射学杂志,2015,(04):306.
QIAN Sheng,LIU Rong,WANG Jian hua,et al.Embolization of hepatic arterio portal shunt in patients with HCC complicated by portal vein tumor thrombus treated with TACE combined with portal vein stenting： its clinical significance[J].journal interventional radiology,2015,(12):306.
[7]刘秋松,梅雀林,李彦豪,等.化疗栓塞治疗肝癌合并肝动-静脉分流的生存预后因素分析[J].介入放射学杂志,2015,(12):1056.
LIU Qiu-song,MEI Que-lin,LI Yan-hao,et al.Interventional chemoembolization for the treatment of hepatocellular carcinoma associated with hepatic arteriovenous shunt： analysis of survival prognostic factors[J].journal interventional radiology,2015,(12):1056.
[8]刘秋松,梅雀林,何晓峰,等.索拉非尼联合PVA微粒化疗栓塞治疗肝癌并肝动-静脉分流的疗效及预后分析[J].介入放射学杂志,2016,(04):320.
LIU Qiu- song,MEI Que- lin,HE Xiao- feng,et al.Sorafenib plus percutaneous chemoembolization with polyvinyl alcohol for hepatocellular carcinoma complicated by hepatic arteriovenous shunts： analysis of curative effect and prognosis[J].journal interventional radiology,2016,(12):320.
[9]黄 芳,龚环宇,熊正平.雷替曲塞联合奥沙利铂TACE治疗BCLC B/C期肝细胞癌的安全性及疗效[J].介入放射学杂志,2018,27(01):76.
HUANG Fang,GONG Huanyu,XIONG Zhengping.The safety and efficacy of raltitrexed combined with oxaliplatin in TACE treatment for BCLC B/C hepatocellular carcinomas[J].journal interventional radiology,2018,27(12):76.
[10]戴高乐,罗万权,赵许亚,等.眼部Merkel细胞癌介入治疗1例[J].介入放射学杂志,2020,29(10):1060.
DAI Gaole,LUO Wanquan,ZHAO Xuya,et al.Successful interventional treatment of Merkel cell carcinoma located at the lateral canthus of left eye： report of one case[J].journal interventional radiology,2020,29(12):1060.
[11]周卫忠,刘 圣,杨正强,等.氰基丙烯酸酯胶栓塞原发性肝细胞癌合并重度肝动脉门静脉瘘12例疗效分析[J].介入放射学杂志,2013,(08):641.
ZHOU Wei? zhong,LIU Sheng,YANG Zheng? qiang,et al. Transarterial embolization therapy with cyanoacrylate for severe arterioportal shunt associated with hepatocellular carcinoma[J].journal interventional radiology,2013,(12):641.
[12]郑家平,邵国良,罗 君,等. 索拉非尼治疗中晚期肝细胞癌安全性和预后因素分析[J].介入放射学杂志,2014,(03):222.
ZHENG Jia? ping,SHAO Guo? liang,LUO Jun,et al. Sorafenib for the treatment of intermediate?蛳 advanced hepatocellular carcinomas： its safety and prognostic factors[J].journal interventional radiology,2014,(12):222.
[13]万豪光,许 伟,徐 浩,等. 经导管化疗栓塞联合经皮微波消融治疗中晚期肝癌64例的预后分析[J].介入放射学杂志,2014,(06):477.
WAN Hao- guang,XU Wei,XU Hao,et al. Transcatheter arterial chemoembolization combined with percutaneous microwave ablation for the treatment of intermediate- advanced hepatocellular carcinoma： analysis of prognostic factors in 64 cases[J].journal interventional radiology,2014,(12):477.
[14]孙 玉,张洪海,生守鹏,等.白蛋白-胆红素分级在早期肝细胞癌射频消融中的预后意义 [J].介入放射学杂志,2021,30(05):502.
SUN Yu,ZHANG Honghai,SHENG Shoupeng,et al.Prognostic significance of albumin-bilirubin grading in patients with early hepatocellular carcinoma after radiofrequency ablation treatment[J].journal interventional radiology,2021,30(12):502.
[15]李 卿,梁 斌.化疗栓塞联合替拉扎明治疗肝癌的研究进展[J].介入放射学杂志,2021,30(08):846.
LI Qing,LIANG Bin..Research progress in the treatment of hepatocellular carcinoma with chemoembolization combined with tirapazamine[J].journal interventional radiology,2021,30(12):846.
[16]中国医师协会介入医师分会临床诊疗指南专委会.肝细胞癌经动脉化疗栓塞抵抗及后续治疗专家共识[J].介入放射学杂志,2022,31(11):1039.
Expert consensus on the TACE failure/refractoriness and its subsequent therapies in treating patients with hepatocellular carcinoma Clinical Guidelines Committee of Chinese College of Interventionalists[J].journal interventional radiology,2022,31(12):1039.